(Q44454368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lorraine A Chantrill

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

N C Tebbutt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

D Zannino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

K Wilson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M M Cummins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

E Abdi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A H Strickland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R M Lowenthal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

G Marx

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Karapetis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Shannon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

D Goldstein

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S S Nayagam

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Blum

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R J Simes

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

T J Price

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Australasian Gastro-Intestinal Trials Group

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

1 reference

27 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1834-1838

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Radiation therapy and tamoxifen: concurrent or sequential? That is the question

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

Thrombosis associated with angiogenesis inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ702

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21273347%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference